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The immunoreactivity for thioredoxin, which catalyzes pro- 
tein disulfide reductions, has previously been shown to ex- 
ist in nerve cells and their axons. Here we demonstrate the 
localization of thioredoxin mRNA as revealed by in situ hy- 
bridization in the rat brain. The gene is expressed in nerve 
cells of a variety of brain regions, for example, the cerebral 
cortex, the piriform cortex, the medial preoptic area, the 
CA3/CA4 region of the hippocampal formation, the dentate 
gyrus, the paraventricular nucleus of the hypothalamus, 
the arcuate nucleus, the substantia nigra pars compacta, 
the locus coeruleus, the ependyma of the 4th ventricle, and 
the epithelial cells of the choroid plexus. This distribution 
implicates an important function in nerve cell metabolism, 
especially in regions with high energy demands and indi- 
cates a role of the choroid plexus in nerve cell protection 
from environmental influences. It was found that after me- 
chanical injury induced by partial unilateral hemitransec- 
tion the thioredoxin mRNA expression is upregulated in the 
lesioned area and spreads to the cortical hemispheres at 
the lesioned level. This induction suggests a function of 
thioredoxin in the regeneration machinery of the brain fol- 
lowing mechanical injury and oxidative stress. 
[Key words: fhioredoxin, mRNA, in situ hybridization, 
brain, rat, hemifransecfion] 
Thioredoxin is a multifunctional 12 kDa protein which catalyzes 
reductions of protein disulfides via an active site dithiol with the 
sequence -Cys-Gly-Pro-Cys-. As part of the thioredoxin system, 
that is, thioredoxin, NADPH, and FAD-containing enzyme thio- 
redoxin reductase, thioredoxin is a hydrogen donor for ribonu- 
cleotide reductase, methionine sulfoxide reductases, or sulfate 
reductase. It is also a general protein disulfide reductase and 
regulates enzyme and protein activity by “thiol redox control” 
(Holmgren, 1985, 1989). 
Thioredoxin has been isolated from a large variety of procar- 
yotic and eukaryotic species, making it ubiquitous (Holmgren 
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1985). In mammals, thioredoxin and thioredoxin reductase are 
widespread in different tissues and not only related to cellular 
growth and DNA synthesis (Holmgren, 1985; Hansson et al., 
1986a,b). High levels of thioredoxin and thioredoxin reductase 
are present in nervous tissue, for example, in nerve cells and 
their axons (Rozell et al., 1985; Stemme et al., 1985). Thiore- 
doxin is localized at intracellular membranes especially in se- 
cretory cells (Hansson et al., 1986a, 1989). Using antisera 
against rat thioredoxin the protein was observed to be widely 
distributed and its immunoreactivity is localized in the cyto- 
plasm and enriched at plasma membranes or in the subplasma 
membrane zone. Thioredoxin levels vary in secretory cells de- 
pendent on their stage of metabolic activity (Hansson et al., 
1986a, 1988, 1989). Recent results have identified thioredoxin 
as a secreted growth factor (Tagaya et al., 1989; Ericson et al., 
1992) and a regulator of transcription factors (Matthews, 1992). 
The cDNA encoding human thioredoxin has been cloned 
(Wollman et al., 1988; Tagaya et al., 1989; Tonissen and Wells, 
1991). It is not known so far, in which nuclei of the mammalian 
brain the message is expressed and how this is related to func- 
tional aspects and electron transport to reductive enzymes. In 
the present article the first demonstration of the cellular local- 
ization and distribution of thioredoxin mRNA levels is given 
together with evidence for an involvement of thioredoxin in 
brain plasticity as seen from an upregulation of thioredoxin 
mRNA levels after a partial mesodiencephalic hemitransection. 
Materials and Methods 
Animals. Male pathogen-free adult Sprague-Dawley rats (200 gm av- 
erage body weight) were used for thioredoxin mRNA localization (four 
rats) and for thioredoxin mRNA localization after partial mesodience- 
phalic hemitransection (20 rats). They were kept under regular lighting 
conditions (lights on 6:00 A.M. and off 8:00 PM.) at constant temuer- 
ature (23°C) &d had free access to food pellets and tap water. - 
Partial meso-diencephalic hemitransection. The anaesthetized rats 
(chloralhydrate 350 mg/kg body weight) were mounted in a stereotactic 
instrument (David Kopf, Tujunga, CA). After drilling out a circular- 
shaped piece of skull bone, the dura was penetrated with a rectangular 
knife (4 mm wide, 1 mm thick at the edge), which was tilted 20” to the 
frontal plane and inserted 1 mm caudal to bregma and 1 mm lateral to 
the midline (bregma - 1.00 mm, L + 1.00 mm; Paxinos and Watson, 
1986). The knife was lowered 10 mm ventrocaudally into the right 
hemisphere. After touching the skull base it was withdrawn 2 mm, 
moved laterally until touching the bone and then removed. 
The lesion cuts ascending and descending pathways including the 
nigrostriatal dopaminergic system with the exception of its most medial 
components (Agnati et al., 1983). As controls sham-operated rats were 
used (four rats). The rats were studied at several time-points after hemi- 
transection: 24 hr, 72 hr, 7 d, 14 d (four rats in each group). 
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The body weight of the hemitransected rats decreased significantly 7 
d after surgery as compared to sham operated rats and was still signif- 
icantly less compared to sham operated rats at the 14 d time interval. 
However, at the 14 d time point the body weight was comparable to 
the basal value (Fuxe et al. 1990). 
Dissection and Jiuation. For in situ hybridization studies the animals 
were anaesthetized with pentobarbital(60 mg/kg body weight) and tran- 
scardially perfused through the left cardiac ventricle with ice-cold 0.9% 
NaCl. The brain was removed and snap frozen in isopentane (-35°C). 
All material was sectioned at a 12 pm thickness in a cryostat (Leica, 
Frigocut, Germany). 
DNA construct. A human thioredoxin cDNA (open reading frame 
coding for 105 amino acid residues) (Tagaya et al., 1989) subcloned 
into plasmid pACA (Ren et al., 1993) was isolated by EcoRI digestion 
and subsequently subcloned into the EcoRI site of the pGEM 32 vector. 
The orieniation-of the insert in different subclones was analyzed by 
nucleotide sequence analysis (Sanger et al., 1977) using T7 RNA poly- 
merase (Promega, Madison, WI). Two subclones with opposite orien- 
tation were selected and digested with SmaI. Sense and antisense RNA 
were obtained using T7 RNA polymerase for in vitro transcription. 
RNA probe synthesis. The probes were synthesized by in vitro tran- 
scription using the T7 RNA polymerase promoter for sense (s) and 
antisense (as) RNA production as well. For this purpose the constructs 
were cut with SmaI. The probes were synthesized according to the 
standard procedure described earlier (Bunnemann et al., 1992). Briefly, 
Y&a-UTP (Du Pont NEN, Boston) was used to label the RNA tran- 
scripts in a mixture containing ribonucleotides, transcription buffer, RN- 
ase inhibitor (Boehringer Mannheim, Germany) and T7 RNA polymer- 
ase (Boehringer Mannheim, FRG) for 90 min at 37’C. Subsequentely, 
the DNA template was removed by treatment with RNase free DNase 
I (Boehringer Mannheim, Germany) for 20 min at 37°C. The transcripts 
were purified chromatographically on NENSORB cartridges (Du Pont- 
NEN, Boston, MA) and checked by denaturing formaldehyde gel elec- 
trophoresis. The specific activity of the probes was in the order of 5 X 
lOa dprn/p.g RNA. 
In situ hybridization. The procedure is described earlier in detail (Lip- 
poldt et al:, 1993). Briefly, the sections were brought to room temper- 
ature. fixed with 4% buffered naraformaldehvde. washed in PBS and 
deproteinized in 0.1 M HCl. Afier additional washing the sections were 
acetylated to avoid unspecific binding. After dehydration in graded eth- 
anols the sections were prehybridized in a humidified chamber with 150 
ml of prehybridization buffer [50% deionized formamide, 50 mrvr Tris- 
HCl pH 7.6, 25 mu EDTA pH 8.0, 20 mu NaCl, 0.25 mg/ml yeast 
tRNA, 2.5 X Denhardt’s solution (0.05% Ficoll, 0.05% polyvinylpyr- 
rolidone, 0.05% bovine serum albumin)] for 2-4 hr. After draining the 
prehybridization buffer off the slides, the sections were hybridized ac- 
cording to the standard procedure using 0.15 ng of labeled s and as 
RNA, respectively. The hybridization was done at 37“C in a buffer 
containing 50% formamide, 1 X Denhardt’s solution, 10% dextransul- 
fate, 0.5 mg/ml yeast tRNA, 0.1 mglml poly-A, and 0.2 M DTf (for 
details, see Lippoldt et al., 1993) for 16-18 hr. Thereafter. the slides 
were washed in 0.5 X SSC/SO% formamide at 48°C for 2 hr, 20 min 
in 1 X SSC at 48°C and subsequently treated with RNase A (10 pg/ 
ml) for 30 min at 37°C and washed several times in 1 X SSC, 0.5 X 
SSC, and 0.2 X SSC at 48°C dehydrated in graded ethanols, dried, and 
exposed on HyperfilmJH films (Amersham, UK) and coated with Ko- 
dak NTB2 emulsion, respectively. The slides were exposed at -20°C 
for 3 weeks on the x-ray films and at 4°C for 6 weeks on emulsion. 
Emulsion coated slides were counterstained with cresyl violet. 
The specificity of the method used was determined by hybridization 
with 35S-a-UTP labeled sense RNA at the same specific activity, length 
and concentration as the antisense RNA. 
Computer-assisted microdensitometry. Semiquantitative data on the 
thioredoxin mRNA levels were obtained by measuring the gray values 
of the film autoradiograms using the microdensitometrical program of 
the IBAS 2.5 (Kontron, Germany) according to a previously published 
microdensitometric method (Zoli et al., 1990). Three measurements 
were performed for each region: (1) the total value, that is, measure- 
ments of the areas in question in the sections hybridized with 35S-a- 
UTP-labeled thioredoxin-antisense RNA; (2) the unspecific value, that 
is, measurements of the corresponding areas in the control sections hy- 
bridized with 3SS-cr-UTP-labeled thioredoxin-sense RNA; and (3) the 
background value, that is, measurements of the film background outside 
the sections. In order to obtain a rostrocaudal evaluation of the labeling 
intensity, the analyses were performed at various coronal levels. The 
autoradiograms were digitized directly via a TV camera (CCD 72/MTi- 
camera) on a screen, allowing the measurement of an entire coronal 
section at once. The areas of interest were selected by means of a light 
pen and the transmissions were measured. The specific values were 
defined as those obtained by subtracting the nonspecific values (sections 
incubated with the labeled sense RNA-probe) from the total values (sec- 
tions incubated with labeled antisense RNA-probe) after correcting for 
the background. Photographs of the in situ autoradiograms were directly 
taken from the x-ray film. Transmissions as well as optical densities 
were obtained utilizing postprocessing programs. 
The measurement for the different regions was done as illustrated in 
Figure 4a for the cortical parts at all time points. Since at the 24 hr 
time interval the tissue within the lesioned area is deteriorated the ex- 
pression within the lesioned area was measured in sections where some 
of the tissue was left, At the other time points the lesion was encircled 
and measured. The sense values were in all cases background values. 
Pictures have been taken directly from the x-ray film. 
For statistical analysis multiple t test was used. As a basis for the 
statistical tests served the mean values of the measured specific trans- 
missions and their standard deviations. 
Results 
Distribution of the thioredoxin mRNA in the rat brain 
The thioredoxin mRNA is widely distributed throughout the rat 
brain. In all areas investigated the thioredoxin mRNA is ex- 
pressed in nerve cells (Fig. 2). 
Telencephalon. High expression can be seen in the cortex 
from the frontal to the occipital level. This expression is local- 
ized in the cingulate cortex, the frontal cortex, the parietal cor- 
tex, the temporal cortex, the piriform cortex, the entorhinal cor- 
tex and the amygdala. There is no significant difference in op- 
tical density from bregma 4.20 mm to bregma -0.40 mm (Fig. 
la). The highest expression shows the piriform cortex, especial- 
ly at bregma 3.20 mm to -0.40 mm (Fig. la). This labeling 
was due to expression of the gene in the granule cells. There 
was no variation in rostro-caudal direction as seen by measure- 
Figure 1. Thioredoxin mRNA distribution in selected regions of the rat brain. a, Thioredoxin gene expression in the rat cerebral cortex. cg, 
Cingulate cortex; jr, frontal cortex; par, parietal cortex. In the piriform cortex (pir) the gene is very highly expressed whereas in the caudate 
putamen (CPU) the expression is only slightly above background level (bregma, 1.7 mm). b, The subfomical organ (SFO) and the supraoptic 
nucleus (SO) are moderately expressing thioredoxin mRNA (bregma, -0.9 mm). c, The paraventricular hypothalamic nucleus (Pa) is one of the 
nuclei expressing the highest amounts of thioredoxin mRNA. The rostra1 part of the supraoptic nucleus (SO) is labeled by thioredoxin mRNA 
(bregma, -2.0 mm). d, In the CA3-CA4 region of the hippocampal formation and the dentate gyrus (DG) the thioredoxin gene is highly expressed, 
whereas the CA1 and CA2 region shows very low gene expression. Within the thalamus the gene is moderately expressed in the ventroposteromedial 
thalamic nucleus (VPM), in the hypothalamus the ventromedial hypothalamic nucleus (VMH) and the arcuate nucleus (Arc) are strongly labeled by 
the thioredoxin mRNA orobe (breama. -3.2 mm). e, The substantia nima pars compacta (SNC) is moderately positive for thioredoxin mRNA 
(bregma, -5.3 mm). f,  The locus ioeruleus (LC)‘is one of the regions with the highest thioredoxin mRNA expression. Mo.5, Motor trigeminal 
nucleus (bregma, -9.8 mm). g, At bregma - 10.5 mm the facial nucleus (7) is strongly positive for thioredoxin mRNA. h, The medulla oblongata 
exhibits structures moderately and highly expressing the thioredoxin gene, that is, the nucleus of the solitary tract (Sol), the dorsal motor nucleus 
of the vagus (IO), the hypoglossal nucleus (12) and in the medial part as well as the lateral parts of the reticular formation (LRt) and the inferior 
olive (IO) (bregma, - 13.7 mm). 
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Figure 2. Cellular localization of 
thioredoxin mRNA using emulsion and 
counterstaining with cresyl violet. a, In 
the niriform cortex thiorecloxin mRNA 
sign& are seen in the densely packed 
nerve cells (arrows). b, A patchy dis- 
tribution of the signals for thioredoxin 
mRNA in the epithelial cells of the 
choroid plexus in the 4th ventricle (4v) 
is seen (arrows). c, Within the para- 
ventricular hypothalamic nucleus the 
thioredoxin gene is expressed in nerve 
cell bodies (arrows). d, In the ventral 
posterolateral thalamic nucleus the 
grains are localized over the big nerve 
cells (arrows). e, In the CA3 region of 
the hippocampal formation the grains 
are localized over the nerve cell nuclei 
(arrows). f, In the inferior olive the 
gene is expressed in large nerve cell 
bodies (arrows). g, The big nerve cells 
of the locus coemleus contain the sig- 
nals for thioredoxin mRNA (arrows). 
h, A big nerve cell of the nucleus trac- 
tus solitarius exhibiting the mRNA sig- 
nal for thioredoxin (arrow), small glial 
cell nuclei do not express thioredoxin 
(arrowhead). Scale bar, 10 ym. 
ments between bregma 3.20 mm to bregma -0.40 mm (Fig. regions show comparable optical densities. The measurements 
la). The caudate putamen shows very low expression of the are made at bregma -2.80 mm to -3.00 mm (Fig. lb). Very 
message, whereas the ependymal cells of the lateral ventricle low amounts of tbioredoxin mRNA expression have been ob- 
express tbioredoxin (Fig. la) (Table 1). served in the CA1 region (Fig. lb). 
In the hippocampal formation the tbioredoxin gene is mainly The basal ganglia including caudate putamen, globus pallidus 
expressed in the nerve cells of the CA3 region but also in the and ventral pallidum show expression of the tbioredoxin gene 
CA4 region and the granule cells of the dentate gyrus. All only slightly above background. Structures related to basal gan- 
Table 1. Distribution of thioredoxin mRNA levels in the rat 
brain as determined with microdensitometry 
Area 
Optical density 
Mean t- SD n 
Telencephalon 
Cerebral Corttex 
Cingulate cortex 
Frontoparietal cortex 
Piiform cortex 
Basal ganglia 
Caudate putamen 
Preoptic region 
Medial preoptic area 
Magnocellular preoptic nut. 
Diencephalon 
Hypothalamus 
Supraoptic nucleus 
Paraventricular hypothalamic nucleus 
Arcuate nucleus 
Ventromedial hypothalamic nucleus 
Thalamus 
Medial habenula 
Subthalamic nucleus 
Ventral posteriolat./posteriomed. 
thal. nut. 
VentrolatNentromed. thal. nut. 
Mesencephalon 
Substantia nigra pars compacta 
Pons 
Locus coeruleus 
Pontine nuclei 
Motor trigeminal nut. 
Medulla oblongata 
Inferior olive 
Nucleus of the solitary tract 
Hypoglossal nucleus 
Fascia1 nucleus 
Lateral reticular nut. 
Choroid plexus (4th ventricle) 
Circumventricular organs 
Subfomical organ 
Hippocampal formation 
CA1 
CA3lCA4 
Dentate gyms 
0.104 + 0.018 5 
0.090 + 0.019 5 
0.129 * 0.038 5 
0.049 2 0.026 3 
0.141 + 0.027 2 
0.101 + 0.018 1 
0.123 + 0.046 1 
0.337 2 0.076 1 
0.224 t 0.052 2 
0.164 + 0.042 3 
0.163 k 0.023 2 
0.205 -t 0.099 1 
0.113 ? 0.023 2 
0.111 + 0.021 2 
0.115 + 0.058 1 
0.379 ? 0.123 2 
0.232 k 0.084 2 
0.168 2 0.045 2 
0.252 5 0.080 3 
0.384 k 0.113 2 
0.285 L 0.044 2 
0.235 + 0.037 2 
0.178 k 0.030 3 
0.126 2 0.038 2 
0.148 2 0.046 1 
0.053 + 0.013 2 
0.149 + 0.040 3 
0.152 + 0.051 3 
n, Number of rostro-caudal levels examined. Means 2 SD are shown out of 
four rats. In each rat and each area at least three sections were measured. 
glia with regard to function such as the substantia nigra and the 
subthalamic nucleus present more intense labeling. Substantia 
nigra is only labeled within the pars compacta as illustrated at 
bregma -4.80 mm to -5.00 mm (Fig. lc) and shows less la- 
beling than the subthalamic nucleus at bregma -3.80 mm to 
-4.16 mm. The magnocellular preoptic nucleus as well as the 
nucleus of the horizontal limb of the diagonal band shows a 
moderate expression of the message. 
Diencephalon. The thioredoxin mRNA was moderately ex- 
pressed within all the preoptic nuclei. Thalamic and hypothalam- 
ic regions contain moderate to high amounts of thioredoxin 
mRNA. Highest expression levels were observed in the para- 
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ventricular hypothalamic nucleus (Fig. If), the arcuate nucleus 
(Fig. lb) and the subthalamic nucleus. Other regions like the 
supraoptic nucleus (Fig. If), the ventromedial hypothalamic nu- 
cleus (Fig. lb), the medial habenula, the ventralposteriolateraY 
posteriomedial thalamic nucleus (Fig. lb) and the ventrolateraY 
ventromedial thalamic nucleus were moderately labeled. 
Pons. The pontine nuclei (bregma: -6.80 mm to -7.00 mm) 
are among the most intensely labeled structures in the rat brain. 
Moreover, the locus coeruleus (bregma: -10.04 mm to -9.7 
mm) is the structure with the most intense labeling among all 
structures measured (Fig. 1 h) and the motor nucleus of the tri- 
geminal nerve (bregma: -9.7 mm) shows moderate expression 
of the thioredoxin gene (Fig. lh). 
Medulla oblongata. The lateral reticular nucleus (LRt) (Fig. 
ld,g) (bregma: -13.7 mm), the nucleus of the solitary tract 
(NTS) (lateral and medial part, bregma: - 13.8 mm to - 13.6 
mm), the fascial nucleus (bregma: - 10.5 mm to - 11.0 mm) 
and the inferior olive (IOC) (bregma: - 13.7 mm) were the most 
intensely labeled structures in the medulla oblongata (Fig. Id). 
Within the medulla oblongata, the NTS shows strong gene ex- 
pression, whereas the IOC, fascial nucleus, and the LRt were 
moderately labeled. 
The 4th ventricle choroid plexus (bregma: - 13.2 mm) shows 
moderate thioredoxin mRNA expression. 
Circumventricular organs. The subfornical organ (bregma: 
-1.4 mm) of the rat brain is moderately labeled (Fig. le), 
whereas no clear signal is observed in the median eminence and 
the area prostrema. 
Partial meso-diencephalic hemitransection 
The thioredoxin mRNA levels are highly upregulated at 24 hr 
around the lesion site and also in the surrounding cortical hemi- 
sphere (retrosplenial and frontoparietal cortices) of the ipsilateral 
side. After 72 hr the increased mRNA signal is more restricted 
to the lesion site and only the frontoparietal part of the cerebral 
cortex is still activated. At the 7 d time interval the expression 
of the thioredoxin gene within the cortical areas is almost nor- 
mal. However, the cells within the lesioned area still show an 
increased labeling. Fourteen days after the surgery the thiore- 
doxin mRNA levels are normalized (Figs. 3,4). The CA1 region 
of the hippocampal formation exhibits a higher level of thiore- 
doxin mRNA expression 24 hr after injury. This expression is 
back to normal control values after 72 hr. 
Discussion 
Thioredoxin mRNA levels are widely distributed throughout the 
rat brain. The highest expression levels have been observed in 
the piriform cortex, the dentate gyrus, the CA3KA4 region of 
the hippocampal formation, the locus coeruleus as well as in 
some regions involved in neuroendocrine and/or cardiovascular 
control such as the paraventricular hypothalamic nucleus and the 
nucleus of the solitary tract. There is little known until now 
about the functional importance of thioredoxin gene expression 
in these regions. Since thioredoxin is a general protein disulfide 
oxido-reductase (Holmgren, 1979) and may regulate protein ac- 
tivity by “thiol-redox control” (Holmgren, 1985, 1989) it should 
have functions in signal transduction. Indeed, Deiss et al. (1991) 
cloned the thioredoxin gene, when the signal transduction path- 
way for interferon was analyzed by genetic techniques. It is 
interesting to note that thioredoxin expression is particularly 
abundant in regions with high energy demands or high activity 
involving redox reactive metabolites such as the substantia nigra 
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Figure 3. Time-dependent expression of thioredoxin mRNA after unilateral partial hemitransection. The thioredoxin mRNA levels of sham operated 
animals (sham) were expressed as optical densities -C SD (shown as parallel dotted lines). The thioredoxin mRNA expression after hemitransection 
was expressed as optical densities (means 2 SD, n = 4) (0). a, Lesioned area (bregma: -2.3 mm to -3.1 mm); b, retrosplenial agranular cortex 
(MA) and retrosplenial granular cortex (RSG) (hregma: -2.3 mm to -3.1 mm); and c, frontoparietal cortex (Fr, Par) (bregma: -2.3 mm to -3.1 
mm). d, CA1 region of the hippocampal formation (bregma: -2.3 mm to -3.1 mm). The measurement for the different regions was undertaken 
as shown in Figure 4a. Statistical analysis was made using multiple t test (***, p < 0.001; **, p C 0.01; *, p < 0.05). 
and the subthalamic nucleus. Roles in keeping enzymes active 
in the presence of oxidizing redox active substrates or a direct 
role in regulating receptor and enzyme function is suggested. 
This would include information handling in the normal unin- 
jured brain. In contrast, the CA1 region of the hippocampal for- 
mation, very well known for the vulnerability of its neurons to 
oxidative stress (Leifer and Kowall, 1993; Ordy et al., 1993; 
Neumann-Haefelin et al., 1994), is characterized by very low 
thioredoxin expression. This could be in part the reason for its 
vulnerability to situations like ischemia. Indeed, it has been 
shown, that glutathione is essential for hippocampal neurons to 
recover from damage by free radicals (Pellmar et al., 1992). 
Previously, the calf brain was found to contain thioredoxin 
(0.05% of wet weight) determined by radioimmunoassay (Holm- 
gren and Luthman, 1978). Immunohistochemical investigations 
showed thioredoxin and thioredoxin reductase to be present in 
the nerve cells in the rat brain (Rozell et al., 1985). Furthermore, 
thioredoxin and thioredoxin reductase were found to be trans- 
ported by axoplasmic transport in the rat sciatic nerve (Stemme 
et al., 1985a). These results and the present investigation with 
localization of thioredoxin mRNA give evidence for the contin- 
ued synthesis of this protein by the nerve cells themselves. In- 
deed, since thioredoxin has been shown to be secreted from 
human B-cells and several other cell types (Ericson et al., 1992; 
Sitia et al., 1992), secretion from nerve cells may help to protect 
cells via anti-oxidative roles of thioredoxin together with glu- 
tathione peroxidase. It was recently shown (Bjornstedt et al., 
1994) that the thioredoxin and glutaredoxin systems are efficient 
electron donors to human plasma glutathione peroxidase, which 
operates in serum devoid of glutathione. 
The present results demonstrate thioredoxin mRNA levels in 
ependymal cells of the 3rd ventricle and in epithelial cells of the 
choroid plexus as well. Here a patchy pattern of gene expression 
was evident. Thioredoxin immunoreactivity has previously been 
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Figure 4. Illustration of the upregulation of thioredoxin mRNA expression after unilateral partial hemitransection as revealed by in situ hybrid- 
ization. a, Thioredoxin mRNA 24 hr after injury, RSG/RSA-retrosplinal granular and agranular cortices, Fr/Par-fronto-parietal cortex. The white 
dotted line shows the ventral border between RSA/RSG and Fr, and the black dotted line shows the border for measurement of the fronto-parietal 
cortex. b illustrates the thioredoxin gene expression 72 hr after the injury; c demonstrates the thioredoxin mRNA after 7 d. The area surrounding 
the lesion is strong labeled for thioredoxin mRNA; d, 14 d after the lesion. The thioredoxin mRNA levels have become normalized (*, lesion site). 
found in many epithelial cells (Rozell et al., 1985; Hansson et 
al., 1988; Padilla et al., 1992) and in the secreting cells of the 
choroid plexus as well (Rozell et al., 1984). The function of 
thioredoxin expressed in the epithelial cells of the choroid plexus 
and ependymal cells of the ventricle may be related to their cell 
metabolism itself, Additionally, the secretion of thioredoxin into 
the cerebrospinal fluid may lead to the protection of nerve cells 
from oxidation by environmental inlluences like reactive oxygen 
intermediates via bulk flow into the extracellular fluid, thus 
maintainig the microenvironment of the brain cells (Nilsson et 
al., 1992). Moreover, thioredoxin could directly influence the 
secretory state of the epithelial cells of the choroid plexus and 
the ependymal cells of the ventricle, probably via control of 
cytoplasmic redoxbalance, as has been shown for the epithelial 
cells of the gastric mucosa and exocrine and endocrine pancreas 
(Hansson et al., 1986, 1988). It may also have a function in 
supporting the transport of substances from the blood to the CSF 
and vice versa by influencing the redox state of the transporter 
systems in the choroid plexus (Ericson et al. 1992). 
Thioredoxin mRNA was also detected in the nigral dopami- 
nergic cells of the zona compacta, which may give it a putative 
role in Parkinson’s disease as suggested previously by Endoh et 
al. (1993). 
Under pathophysiological conditions such as head trauma 
(mechanical injury), it is shown in the present article that the 
expression of the thioredoxin gene is strongly induced in the 
lesioned area reaching into cortical regions of the ipsilateral 
hemisphere. The CA1 region of the hippocampal formation 
shows only a slight transient upregulation of the thioredoxin 
mRNA after the lesion. However, the cellular location of this 
increased thioredoxin mRNA signal still remains to be deter- 
mined, but it may be linked to activated glial cells since the 
region surrounding the lesion is filled up with activated astroglial 
and microglial cells. However, in the uninjured brain the glial 
cells have been shown to lack thioredoxin immunoreactivity 
(Rozell et al., 1985; Hansson et al., 1989). The thioredoxin 
mRNA induction is an early event and occurs already 24 hr after 
injury. Since reactive oxygen intermediates play a crucial role 
in tissue damage after injury, the upregulation of the thioredoxin 
gene expression may be due to the involvement of the thiore- 
doxin in protecting the lesioned area from active oxygen inter- 
mediates. As a result of such active oxygen intermediates, the 
methionine residues may be oxidized to methionine sulphoxide 
residues in proteins and thioredoxin together with methionine 
sulphoxide reductases will repair such proteins. Furthermore, 
many proteins will contain artificial disulfide bonds which may 
be reduced by thioredoxin reductase NADPH and thioredoxin. 
It appears that thioredoxin mRNA is induced following some 
signalling on the gene level involving increased oxidative stress 
via an as yet unknown mechanism. Particularly, interesting has 
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Figure 5. Cresyl violet staining of the 
hemitransected region 7 d after the par- 
tial unilateral hemitransection. a, Mor- 
phology of the lesion near the parietal 
cortex (par). The lesioned region (on 
the left-hand side of the dotted line) 
demonstrates densely packed small cell 
nuclei probably related to different 
types of glial cells (arrows). b, Densely 
packed small glial cell nuclei are char- 
acteristric for the tissue repair via gli- 
osis within the lesioned area (arrows). 
Scale bar, 50 pm. 
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been the information in recent years that thioredoxin is involved 
in the regulation of a number of transcription factors including 
NF-KB, AP-1, TF3C, TZLFl, and myb. In the case of NF-KB, 
it has been shown both in vitro and in vivo that human thiore- 
doxin is responsible for the activation of the DNA binding prop- 
erties by specifically reducing a disulfide bond involving a crit- 
ical cysteine residue at position 62 in the P50 subunit (Abate et 
al., 1990; Matthews et al., 1992; Hayashi et al., 1993; Mitomo 
et al., 1994). The slight and transient increase in thioredoxin 
mRNA in the CA1 subfield of the hippocampus after the lesion 
may be one reason for its high vulnerability to increased oxi- 
dative stress and to the late onset of neuronal activation as seen 
by c-fos expression (Neumann-Haefelin et al. 1994). 
It should also be noted that thioredoxin has been identified as 
a highly expressed cytokine-like factor in activated T- and 
B-cells which upregulates the interleukin-2 receptor a-chain and 
interleukin-2, both of which are under the transcriptional control 
of NF-kB (Tagaya et al., 1989; Wakasugi et al., 1990). A pro- 
tective role for damaged neuronal cells may thus be visioned for 
thioredoxin secreted from glial cells or in particular from mi- 
croglia/macrophages in the damaged ipsilateral area. Direct in- 
volvement of thioredoxin in transcriptional control activity with 
a variety of genes in the injured area in activated cells is a likely 
result. Repair mechanisms would also require DNA synthesis 
and thioredoxin is a hydrogen donor for ribonucleotide reductase 
and a redox regulator of the enzyme. In the case of injury, it 
may be able to supply the deoxyribonucleotides for DNA syn- 
thesis in dividing glial cells and channel nucleotides for repair 
in nerve cells. 
Several recent reports suggest that thioredoxin may have im- 
portant, but as yet undefined co-cytokine activities under patho- 
physiological conditions involving oxidative stress. This in- 
cludes observations with hydrogen peroxide (Spector et al., 
1988) as well as with TNF-a (Matsuda et al., 1991) or experi- 
mental ischemia (Endoh et al., 1993; Tomimoto et al., 1993). 
Thioredoxin has also been shown to modify the glucocorticoid 
receptor to a steroid binding site by reduction (Grippo et al., 
1985). A specific role for thioredoxin in reticular site initiation 
of protein synthesis has been shown (Holmgren, 1985). 
In conclusion, the thioredoxin gene expression has been 
shown to be widely distributed but preferentially located in dis- 
tinct nerve cell populations in the rat brain. It is also strongly 
induced under pathophysiological conditions such as mechanical 
injury. Thus, one role of thioredoxin may be to form an essential 
signal molecule and functional part of the DNA regeneration 
processes in the activated glial cells of the brain, which remains 
to be determined in more detail. 
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